Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ajit Suri"'
Autor:
Hiroaki Itamochi, Nobuhiro Takeshima, Junzo Hamanishi, Kosei Hasegawa, Motoki Matsuura, Kiyonori Miura, Shoji Nagao, Hidekatsu Nakai, Naotake Tanaka, Hideki Tokunaga, Shin Nishio, Hidemichi Watari, Yoshihito Yokoyama, Yoichi Kase, Shuuji Sumino, Ai Kato, Ajit Suri, Toshiaki Yasuoka, Kazuhiro Takehara
Publikováno v:
Journal of Gynecologic Oncology; Sep2024, Vol. 35 Issue 5, p1-12, 12p
Autor:
David B. Agus, Iain J. Webb, Yuanjun Shi, Mitchell E. Gross, John Hainsworth, Omid Hamid, Gary R. MacVicar, Lowell Hart, Daniel Shevrin, Walter M. Stadler, Ajit Suri, David MacLean, Robert Dreicer
Purpose: The androgen receptor pathway remains active in men with prostate cancer whose disease has progressed following surgical or medical castration. Orteronel (TAK-700) is an investigational, oral, nonsteroidal, selective, reversible inhibitor of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b8e4b1833b7f3adbaa2d02c839a5788
https://doi.org/10.1158/1078-0432.c.6521592
https://doi.org/10.1158/1078-0432.c.6521592
Autor:
David B. Agus, Iain J. Webb, Yuanjun Shi, Mitchell E. Gross, John Hainsworth, Omid Hamid, Gary R. MacVicar, Lowell Hart, Daniel Shevrin, Walter M. Stadler, Ajit Suri, David MacLean, Robert Dreicer
PDF file - 65K, Schedule of assessments.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64346251ea584c498f27c381ff4abcc0
https://doi.org/10.1158/1078-0432.22449246.v1
https://doi.org/10.1158/1078-0432.22449246.v1
Publikováno v:
Clinical and Translational Science
Autor:
A.S. Dogan, Kathleen Biziere, Steven L. Bramer, Ajit Suri, Fuji Yokoi, Gerhard Gründer, Massoud Stephane, Hayden T. Ravert, Robert F. Dannals, Dean F. Wong
Publikováno v:
Neuropsychopharmacology. 27:248-259
Aripiprazole (OPC 14597) is an antipsychotic drug that has high affinity for dopamine D2 and D3 receptors and the dopamine autoreceptor. It is being developed for treatment of patients with schizophrenia. The purpose of this study was to determine wh
Publikováno v:
Biopharmaceuticsdrug disposition. 35(9)
Orteronel is a nonsteroidal, selective inhibitor of 17,20-lyase that was recently in phase 3 clinical development as a treatment for castration-resistant prostate cancer. In humans, the primary clearance route for orteronel is renal excretion. Human
Autor:
Julio Rosenstock, Bernard L. Silverman, Ajit Suri, Bin Sun, Amparo de la Peña, Douglas B. Muchmore, Masako Nakano
Publikováno v:
Diabetes technologytherapeutics. 9(1)
The Lilly/Alkermes human insulin inhalation powder (HIIP) delivery system [AIR (a registered trademark of Alkermes, Inc., Cambridge, MA) Inhaled Insulin System] was designed to be easy to use. Training methods were compared in insulin-naive patients
Publikováno v:
Journal of clinical anesthesia. 10(6)
Study Objective: To determine the effect of dilution with intravascular volume expanders commonly used by anesthesiologists on clinically relevant levels of free serum ketorolac. Design: In vitro study. Setting: Pharmaceutics laboratory of a medical
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 16(1)
CI-1010, a 2-nitroimidazole, is a chiral prodrug for the active moiety PD 146923 and is under development as an alkylating radiosensitizer to be used as an adjuvant to radiotherapy. Because CI-1010 has an estimated half-lifeor = 2 min under physiolog
Publikováno v:
Journal of clinical pharmacology. 36(12)
Pain assessment in human volunteers is difficult, and it often requires a large number of subjects to show analgesic efficacy with statistical significance. Electrical tooth pulp stimulation elicits a painful sensation and produces an electroencephal